My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    Topical aldose reductase inhibitor.

    Coster D.

    Br J Ophthalmol. 1995 Dec;79(12):1064-5. No abstract available. PMID: 8562535 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.

    Ohguro N, Matsuda M, Ohashi Y, Fukuda M.

    Br J Ophthalmol. 1995 Dec;79(12):1074-7.PMID: 8562538 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The effect of aldose reductase inhibitor on the corneal epithelium.

    Tsubota K, Yamada M.

    Cornea. 1993 Mar;12(2):161-2.PMID: 8500324 [PubMed - indexed for MEDLINE]Related articles

    4.

    Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.

    Ohashi Y, Matsuda M, Hosotani H, Tano Y, Ishimoto I, Fukuda M, Manabe R.

    Am J Ophthalmol. 1988 Mar 15;105(3):233-8.PMID: 3125744 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor]

    Terubayashi H, Akagi Y, Takahashi Y, Ikebe H, Miyamoto Y, Ibaraki N, Yokoi N, Tutumi M, Itoi M.

    Nippon Ganka Gakkai Zasshi. 1988 Jan;92(1):151-5. Japanese. No abstract available. PMID: 3133928 [PubMed - indexed for MEDLINE]Related articles

    6.

    Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.

    Hosotani H, Ohashi Y, Yamada M, Tsubota K.

    Am J Ophthalmol. 1995 Mar;119(3):288-94.PMID: 7872388 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intraocular penetration of CT-112, an aldose reductase inhibitor, following topical instillation.

    Ohashi Y, Awata T, Sogo S, Ohira M, Matsuda M, Fukuda M, Manabe R.

    J Ocul Pharmacol. 1989 Winter;5(4):325-8.PMID: 2516866 [PubMed - indexed for MEDLINE]Related articles

    8.

    Discoveries in research on diabetic keratopathy.

    Cisarik-Fredenburg P.

    Optometry. 2001 Nov;72(11):691-704. Review.PMID: 12363257 [PubMed - indexed for MEDLINE]Related articles

    9.

    Topical hyperosmolar solutions in the reduction of corneal edema.

    Insler MS, Benefield DW, Ross EV.

    CLAO J. 1987 May-Jun;13(3):149-51. No abstract available. PMID: 3449294 [PubMed - indexed for MEDLINE]Related articles

    10.

    Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study.

    Fujishima H, Shimazaki J, Yagi Y, Tsubota K.

    Cornea. 1996 Jul;15(4):368-75.PMID: 8776562 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.

    Hosotani H, Ohashi Y, Kinoshita S, Matsumoto T, Awata T.

    Curr Eye Res. 1996 Oct;15(10):1005-7.PMID: 8921238 [PubMed - indexed for MEDLINE]Related articles

    12.

    Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats.

    Kubo E, Nakamura S, Tsuzuki S, Takahashi Y, Akagi Y, Mizuno K, Matsubara A.

    Graefes Arch Clin Exp Ophthalmol. 1999 Sep;237(9):758-62.PMID: 10447652 [PubMed - indexed for MEDLINE]Related articles

    13.

    Corneal endothelial changes in patients with chronic renal failure.

    Ohguro N, Matsuda M, Fukuda M.

    Am J Ophthalmol. 1999 Aug;128(2):234-6.PMID: 10458183 [PubMed - indexed for MEDLINE]Related articles

    14.

    A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.

    Nakahara M, Miyata K, Otani S, Miyai T, Nejima R, Yamagami S, Amano S.

    Br J Ophthalmol. 2005 Mar;89(3):266-8.PMID: 15722300 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Neurotrophic corneal endothelial failure complicating acute Horner syndrome.

    Zamir E, Chowers I, Banin E, Frucht-Pery J.

    Ophthalmology. 1999 Sep;106(9):1692-6.PMID: 10485536 [PubMed - indexed for MEDLINE]Related articles

    16.

    Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.

    El-Kabbani O, Carbone V, Darmanin C, Oka M, Mitschler A, Podjarny A, Schulze-Briese C, Chung RP.

    J Med Chem. 2005 Aug 25;48(17):5536-42.PMID: 16107153 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of topical mitomycin C on corneal endothelium.

    Panda A, Pe'er J, Aggarwal A, Das H, Kumar A, Mohan S.

    Am J Ophthalmol. 2008 Apr;145(4):635-638. Epub 2008 Feb 1.PMID: 18242576 [PubMed - indexed for MEDLINE]Related articles

    18.

    Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.

    Takemoto DJ, Harris R, Brightman A, McGill J, Hua D, Davidson H, Fenwick B, Wagner LM.

    Vet Ophthalmol. 2004 May-Jun;7(3):163-7.PMID: 15091323 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235.

    Fujishima H, Tsubota K.

    Br J Ophthalmol. 2002 Aug;86(8):860-3.PMID: 12140204 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites.

    El-Kabbani O, Podjarny A.

    Cell Mol Life Sci. 2007 Aug;64(15):1970-8. Review.PMID: 17497245 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity